{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011978","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2022-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.538491+00:00","generated_at":"2026-06-24T23:35:56.264175+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Eledon Pharmaceuticals annual meeting elects directors and ratifies auditor","bullets":["Stockholders elected Keith A. Katkin (7,330,714 for, 765,231 withhold) and John S. McBride (7,287,222 for, 808,723 withhold) as Class II directors for term ending 2025.","Ratified KMJ Korbin & Company LLP as independent auditor for FY2022 with 10,173,336 for, 10,380 against, 3,433 abstain.","All proposals passed at the June 21, 2022 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011978","json":"https://secwatch.observer/filing/0000950170-22-011978.json","markdown":"https://secwatch.observer/filing/0000950170-22-011978.md","text":"https://secwatch.observer/filing/0000950170-22-011978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/0000950170-22-011978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/eldn-20220622.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:35:56.264175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}